SCHEMBL4556285

SCHEMBL4556285

N#Cc1cc(Cl)cc(Oc2c(Cl)ccc3c2N=N[N]3)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.44
CYP3A4 P08684 6/20 0.41
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 1/20 0.34
CYP19A1 P11511 1/20 0.34
SLC22A12 Q96S37 1/20 0.33
PPARG P37231 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
VEGFA P15692 2/20 0.31
EPAS1 Q99814 2/20 0.31
NPBWR1 P48145 1/20 0.31
MCHR1 Q99705 1/20 0.31
CYP2D6 P10635 1/20 0.31
HTR2A P28223 2/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2511368 0.76 KCNH2 (0.45) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL3033135 0.73 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL2393895 0.71 CYP3A4 (0.52) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL3099321 0.71 KCNH2 (0.45) KCNH2CYP3A4CYP2C9CYP2C19CYP19A1
SCHEMBL2884021 0.71 KCNH2 (0.48) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL3031457 0.70 CYP3A4 (0.46) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL3022872 0.70 CYP3A4 (0.46) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL2883149 0.70 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
Bromide SCHEMBL4556525 0.70 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL2881365 0.70 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121638-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008076225-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK & CO., INC. (US) 2008-06-26 WO disclosed